Pharma Pulse: FDA’s Regulatory Revolution and Astellas’ $2 Billion Prostate Cancer Bet

In today’s Pharma Pulse, the FDA unveils a Plausible Mechanism framework to fast-track ultra-rare disease therapies, while Astellas partners with Vir Biotechnology in a massive $2.1 billion oncology collaboration.